Merit Medical Systems, Inc. (MMSI)
USD 97.13
(-1.89%)
USD 97.13
(-1.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.25 Billion USD | 8.89% |
| 2022 | 1.15 Billion USD | 7.09% |
| 2021 | 1.07 Billion USD | 11.5% |
| 2020 | 963.87 Million USD | -3.11% |
| 2019 | 994.85 Million USD | 12.7% |
| 2018 | 882.75 Million USD | 21.28% |
| 2017 | 727.85 Million USD | 20.54% |
| 2016 | 603.83 Million USD | 11.38% |
| 2015 | 542.14 Million USD | 6.37% |
| 2014 | 509.68 Million USD | 13.5% |
| 2013 | 449.04 Million USD | 13.89% |
| 2012 | 394.28 Million USD | 9.69% |
| 2011 | 359.44 Million USD | 21.13% |
| 2010 | 296.75 Million USD | 15.26% |
| 2009 | 257.46 Million USD | 13.35% |
| 2008 | 227.14 Million USD | 9.33% |
| 2007 | 207.76 Million USD | 8.97% |
| 2006 | 190.67 Million USD | 14.46% |
| 2005 | 166.58 Million USD | 10.03% |
| 2004 | 151.39 Million USD | 11.36% |
| 2003 | 135.95 Million USD | 16.97% |
| 2002 | 116.22 Million USD | 11.72% |
| 2001 | 104.03 Million USD | 13.77% |
| 2000 | 91.44 Million USD | 17.24% |
| 1999 | 78 Million USD | 14.04% |
| 1998 | 68.4 Million USD | 12.87% |
| 1997 | 60.6 Million USD | 20.0% |
| 1996 | 50.5 Million USD | 18.54% |
| 1995 | 42.6 Million USD | 27.93% |
| 1994 | 33.3 Million USD | 31.1% |
| 1993 | 25.4 Million USD | 38.04% |
| 1992 | 18.4 Million USD | 75.24% |
| 1991 | 10.5 Million USD | 138.64% |
| 1990 | 4.4 Million USD | 214.29% |
| 1989 | 1.4 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 339.84 Million USD | 0.67% |
| 2024 Q2 | 337.57 Million USD | 4.35% |
| 2024 Q1 | 323.5 Million USD | 0.07% |
| 2023 Q2 | 320.05 Million USD | 7.56% |
| 2023 Q3 | 315.23 Million USD | -1.51% |
| 2023 Q4 | 323.28 Million USD | 2.56% |
| 2023 FY | 1.25 Billion USD | 8.89% |
| 2023 Q1 | 297.56 Million USD | 1.41% |
| 2022 Q4 | 293.41 Million USD | 2.17% |
| 2022 Q3 | 287.17 Million USD | -2.64% |
| 2022 Q2 | 294.97 Million USD | 7.1% |
| 2022 FY | 1.15 Billion USD | 7.09% |
| 2022 Q1 | 275.41 Million USD | -1.1% |
| 2021 Q2 | 280.32 Million USD | 12.62% |
| 2021 Q3 | 267.02 Million USD | -4.75% |
| 2021 Q4 | 278.49 Million USD | 4.3% |
| 2021 FY | 1.07 Billion USD | 11.5% |
| 2021 Q1 | 248.91 Million USD | -3.52% |
| 2020 Q1 | 243.52 Million USD | -5.58% |
| 2020 Q3 | 243.97 Million USD | 11.73% |
| 2020 Q4 | 258 Million USD | 5.75% |
| 2020 FY | 963.87 Million USD | -3.11% |
| 2020 Q2 | 218.37 Million USD | -10.33% |
| 2019 Q2 | 255.53 Million USD | 7.21% |
| 2019 Q3 | 243.04 Million USD | -4.89% |
| 2019 Q4 | 257.92 Million USD | 6.12% |
| 2019 FY | 994.85 Million USD | 12.7% |
| 2019 Q1 | 238.34 Million USD | 2.19% |
| 2018 FY | 882.75 Million USD | 21.28% |
| 2018 Q2 | 224.81 Million USD | 10.72% |
| 2018 Q4 | 233.24 Million USD | 5.23% |
| 2018 Q1 | 203.03 Million USD | 6.36% |
| 2018 Q3 | 221.65 Million USD | -1.4% |
| 2017 Q3 | 179.33 Million USD | -3.87% |
| 2017 FY | 727.85 Million USD | 20.54% |
| 2017 Q4 | 190.89 Million USD | 6.45% |
| 2017 Q2 | 186.54 Million USD | 9.05% |
| 2017 Q1 | 171.06 Million USD | 8.47% |
| 2016 Q4 | 157.71 Million USD | 0.47% |
| 2016 Q1 | 138.07 Million USD | -0.24% |
| 2016 Q2 | 151.07 Million USD | 9.41% |
| 2016 Q3 | 156.97 Million USD | 3.91% |
| 2016 FY | 603.83 Million USD | 11.38% |
| 2015 FY | 542.14 Million USD | 6.37% |
| 2015 Q2 | 138.08 Million USD | 6.56% |
| 2015 Q4 | 138.4 Million USD | 1.7% |
| 2015 Q1 | 129.57 Million USD | -2.41% |
| 2015 Q3 | 136.08 Million USD | -1.45% |
| 2014 Q4 | 132.78 Million USD | 3.08% |
| 2014 Q3 | 128.8 Million USD | -0.04% |
| 2014 Q2 | 128.86 Million USD | 8.08% |
| 2014 FY | 509.68 Million USD | 13.5% |
| 2014 Q1 | 119.23 Million USD | -0.65% |
| 2013 Q2 | 109.87 Million USD | 5.7% |
| 2013 FY | 449.04 Million USD | 13.89% |
| 2013 Q4 | 120.01 Million USD | 4.17% |
| 2013 Q1 | 103.94 Million USD | 1.68% |
| 2013 Q3 | 115.21 Million USD | 4.86% |
| 2012 Q3 | 95.9 Million USD | -4.6% |
| 2012 Q4 | 102.23 Million USD | 6.59% |
| 2012 Q2 | 100.53 Million USD | 5.14% |
| 2012 Q1 | 95.61 Million USD | 4.97% |
| 2012 FY | 394.28 Million USD | 9.69% |
| 2011 Q1 | 86.63 Million USD | 6.68% |
| 2011 Q3 | 90.47 Million USD | -0.85% |
| 2011 FY | 359.44 Million USD | 21.13% |
| 2011 Q2 | 91.24 Million USD | 5.33% |
| 2011 Q4 | 91.09 Million USD | 0.68% |
| 2010 FY | 296.75 Million USD | 15.26% |
| 2010 Q2 | 74.94 Million USD | 11.15% |
| 2010 Q3 | 73.17 Million USD | -2.37% |
| 2010 Q4 | 81.2 Million USD | 10.98% |
| 2010 Q1 | 67.43 Million USD | -0.09% |
| 2009 Q4 | 67.49 Million USD | 1.1% |
| 2009 FY | 257.46 Million USD | 13.35% |
| 2009 Q1 | 58.37 Million USD | 0.65% |
| 2009 Q2 | 64.83 Million USD | 11.08% |
| 2009 Q3 | 66.75 Million USD | 2.96% |
| 2008 Q2 | 57.44 Million USD | 7.26% |
| 2008 Q3 | 58.15 Million USD | 1.24% |
| 2008 Q4 | 57.99 Million USD | -0.27% |
| 2008 FY | 227.14 Million USD | 9.33% |
| 2008 Q1 | 53.55 Million USD | -1.45% |
| 2007 Q2 | 51.81 Million USD | 1.53% |
| 2007 Q4 | 54.34 Million USD | 7.43% |
| 2007 FY | 207.76 Million USD | 8.97% |
| 2007 Q1 | 51.03 Million USD | 0.42% |
| 2007 Q3 | 50.58 Million USD | -2.37% |
| 2006 Q1 | 45.04 Million USD | 5.52% |
| 2006 Q2 | 48.12 Million USD | 6.84% |
| 2006 Q3 | 46.69 Million USD | -2.96% |
| 2006 Q4 | 50.81 Million USD | 8.82% |
| 2006 FY | 190.67 Million USD | 14.46% |
| 2005 Q4 | 42.68 Million USD | 3.54% |
| 2005 Q3 | 41.22 Million USD | -2.79% |
| 2005 Q2 | 42.4 Million USD | 5.29% |
| 2005 Q1 | 40.27 Million USD | 2.38% |
| 2005 FY | 166.58 Million USD | 10.03% |
| 2004 Q2 | 38.92 Million USD | 3.34% |
| 2004 Q3 | 35.47 Million USD | -8.85% |
| 2004 Q4 | 39.33 Million USD | 10.89% |
| 2004 FY | 151.39 Million USD | 11.36% |
| 2004 Q1 | 37.66 Million USD | 7.22% |
| 2003 Q1 | 31.74 Million USD | 7.87% |
| 2003 FY | 135.95 Million USD | 16.97% |
| 2003 Q2 | 34.57 Million USD | 8.93% |
| 2003 Q4 | 35.12 Million USD | 1.8% |
| 2003 Q3 | 34.5 Million USD | -0.2% |
| 2002 Q4 | 29.42 Million USD | 0.28% |
| 2002 Q1 | 28.67 Million USD | 13.38% |
| 2002 Q2 | 28.78 Million USD | 0.41% |
| 2002 Q3 | 29.34 Million USD | 1.92% |
| 2002 FY | 116.22 Million USD | 11.72% |
| 2001 Q3 | 25.69 Million USD | -2.17% |
| 2001 Q4 | 25.28 Million USD | -1.58% |
| 2001 Q2 | 26.26 Million USD | -1.96% |
| 2001 FY | 104.03 Million USD | 13.77% |
| 2001 Q1 | 26.78 Million USD | 19.14% |
| 2000 Q3 | 23.33 Million USD | -0.95% |
| 2000 Q1 | 22.08 Million USD | 3.18% |
| 2000 Q2 | 23.55 Million USD | 6.67% |
| 2000 Q4 | 22.48 Million USD | -3.63% |
| 2000 FY | 91.44 Million USD | 17.24% |
| 1999 Q3 | 19.9 Million USD | 4.74% |
| 1999 Q1 | 17.7 Million USD | 2.31% |
| 1999 Q4 | 21.4 Million USD | 7.54% |
| 1999 Q2 | 19 Million USD | 7.34% |
| 1999 FY | 78 Million USD | 14.04% |
| 1998 Q3 | 16.7 Million USD | -7.22% |
| 1998 Q2 | 18 Million USD | 9.09% |
| 1998 Q1 | 16.5 Million USD | 3.13% |
| 1998 Q4 | 17.3 Million USD | 3.59% |
| 1998 FY | 68.4 Million USD | 12.87% |
| 1997 FY | 60.6 Million USD | 20.0% |
| 1997 Q1 | 13.8 Million USD | 6.15% |
| 1997 Q4 | 16 Million USD | 3.23% |
| 1997 Q3 | 15.5 Million USD | 1.31% |
| 1997 Q2 | 15.3 Million USD | 10.87% |
| 1996 Q2 | 12.7 Million USD | 4.96% |
| 1996 FY | 50.5 Million USD | 18.54% |
| 1996 Q3 | 12.7 Million USD | 0.0% |
| 1996 Q4 | 13 Million USD | 2.36% |
| 1996 Q1 | 12.1 Million USD | 11.01% |
| 1995 FY | 42.6 Million USD | 27.93% |
| 1995 Q4 | 10.9 Million USD | -3.54% |
| 1995 Q3 | 11.3 Million USD | 5.61% |
| 1995 Q2 | 10.7 Million USD | 10.31% |
| 1995 Q1 | 9.7 Million USD | 8.99% |
| 1994 Q4 | 8.9 Million USD | 9.88% |
| 1994 FY | 33.3 Million USD | 31.1% |
| 1994 Q1 | 8 Million USD | 12.68% |
| 1994 Q2 | 8.3 Million USD | 3.75% |
| 1994 Q3 | 8.1 Million USD | -2.41% |
| 1993 Q2 | 6 Million USD | 1.69% |
| 1993 FY | 25.4 Million USD | 38.04% |
| 1993 Q1 | 5.9 Million USD | 11.32% |
| 1993 Q4 | 7.1 Million USD | 10.94% |
| 1993 Q3 | 6.4 Million USD | 6.67% |
| 1992 Q2 | 4.5 Million USD | 12.5% |
| 1992 Q1 | 4 Million USD | 14.29% |
| 1992 Q3 | 4.6 Million USD | 2.22% |
| 1992 FY | 18.4 Million USD | 75.24% |
| 1992 Q4 | 5.3 Million USD | 15.22% |
| 1991 FY | 10.5 Million USD | 138.64% |
| 1991 Q1 | 2 Million USD | 17.65% |
| 1991 Q3 | 2.7 Million USD | 17.39% |
| 1991 Q4 | 3.5 Million USD | 29.63% |
| 1991 Q2 | 2.3 Million USD | 15.0% |
| 1990 Q1 | 600 Thousand USD | 100.0% |
| 1990 Q3 | 1.2 Million USD | 33.33% |
| 1990 Q4 | 1.7 Million USD | 41.67% |
| 1990 FY | 4.4 Million USD | 214.29% |
| 1990 Q2 | 900 Thousand USD | 50.0% |
| 1989 FY | 1.4 Million USD | 0.0% |
| 1989 Q4 | 300 Thousand USD | -25.0% |
| 1989 Q3 | 400 Thousand USD | 0.0% |
| 1989 Q1 | 400 Thousand USD | 0.0% |
| 1989 Q2 | 400 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -1201.177% |
| AngioDynamics, Inc. | 303.91 Million USD | -313.724% |
| AtriCure, Inc. | 399.24 Million USD | -214.936% |
| Avinger, Inc. | 7.65 Million USD | -16331.861% |
| Azenta, Inc. | 665.07 Million USD | -89.057% |
| BioLife Solutions, Inc. | 143.27 Million USD | -777.614% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 65.007% |
| Daxor Corporation | 1.28 Million USD | -98092.212% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -6778.746% |
| Femasys Inc. | 1.07 Million USD | -117194.887% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -1020.148% |
| Hologic, Inc. | 4.03 Billion USD | 68.802% |
| ICU Medical, Inc. | 2.25 Billion USD | 44.343% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 82.351% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -4309.078% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -549.855% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -109000.99% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -109000.99% |
| Masimo Corporation | 2.04 Billion USD | 38.608% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -1194.933% |
| Nephros, Inc. | 14.23 Million USD | -8731.058% |
| NovoCure Limited | 509.33 Million USD | -146.863% |
| NEXGEL, Inc. | 4.08 Million USD | -30649.963% |
| NEXGEL, Inc. | 4.08 Million USD | -30649.963% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -43093.61% |
| OraSure Technologies, Inc. | 405.47 Million USD | -210.099% |
| Pro-Dex, Inc. | 53.84 Million USD | -2235.202% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -70534.849% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -6481.569% |
| QuidelOrtho Corporation | 2.99 Billion USD | 58.057% |
| Repligen Corporation | 638.76 Million USD | -96.844% |
| Sanara MedTech Inc. | 64.98 Million USD | -1834.712% |
| STAAR Surgical Company | 322.41 Million USD | -289.984% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -2403.516% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 68.288% |
| Jin Medical International Ltd. | 19.82 Million USD | -6243.459% |